Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma

Background/Objective: In <10% of cases, pheochromocytomas coexist with other tumors, most commonly ganglioneuromas, and are termed composite pheochromocytoma-ganglioneuromas. We present 2 cases of composite pheochromocytoma-ganglioneuromas and review the diagnosis and management of these rare tum...

Full description

Saved in:
Bibliographic Details
Main Authors: Mayssam El Najjar, MD, Elie Naous, MD, Caroline Blake, Aysegul Bulut, MD, Alexander Perepletchikov, MD, Ann T. Sweeney, MD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:AACE Clinical Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060524001123
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841528024425562112
author Mayssam El Najjar, MD
Elie Naous, MD
Caroline Blake
Aysegul Bulut, MD
Alexander Perepletchikov, MD
Ann T. Sweeney, MD
author_facet Mayssam El Najjar, MD
Elie Naous, MD
Caroline Blake
Aysegul Bulut, MD
Alexander Perepletchikov, MD
Ann T. Sweeney, MD
author_sort Mayssam El Najjar, MD
collection DOAJ
description Background/Objective: In <10% of cases, pheochromocytomas coexist with other tumors, most commonly ganglioneuromas, and are termed composite pheochromocytoma-ganglioneuromas. We present 2 cases of composite pheochromocytoma-ganglioneuromas and review the diagnosis and management of these rare tumors. Case Report: Patient 1 and patient 2 were 35-year-old and 45-year-old woman, respectively. Patient 1 presented with a history of controlled hypertension and symptoms of anxiety along with palpitations, diaphoresis, and flushing. Patient 2 complained of abdominal pain and underwent abdominal computed tomography (CT) imaging. Patient 1 and patient 2 had metanephrine levels of 76 pg/mL and 61 pg/mL (normal <57 pg/mL), respectively, and normetanephrine levels of 161 pg/mL and 116 pg/mL (normal < 148 pg/mL), respectively. CT scans depicted right adrenal masses in both cases: patient 1 had a 2.3 × 2.6 cm mass measuring 36 Hounsfield units on noncontrast CT imaging and patient 2 had a 4.5 × 3.5 cm right adrenal mass measuring 73 Hounsfield units on contrast CT imaging. Both patients underwent laparoscopic robotic adrenalectomies without complications. The pathologic analyses of both cases revealed composite pheochromocytoma-ganglioneuroma tumors. Surveillance at 1 year in both patients demonstrated no evidence of recurrence. Discussion: The clinical and radiological presentation of composite pheochromocytoma-ganglioneuromas mirrors pheochromocytomas. The diagnosis relies on histopathological analysis. Treatment of pheochromocytoma-ganglioneuromas is complete surgical excision in a high-volume center with adrenal expertise and is associated with an overall excellent prognosis. The probability of recurrence is low, and distant metastases have rarely been reported. Conclusion: Pheochromocytoma-ganglioneuromas may present with plasma metanephrine levels in the subclinical range. As with isolated pheochromocytomas, lifetime surveillance is critical for composite pheochromocytoma-ganglioneuromas.
format Article
id doaj-art-bc4f70d4474f420a9bb7bf3521d3e716
institution Kabale University
issn 2376-0605
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series AACE Clinical Case Reports
spelling doaj-art-bc4f70d4474f420a9bb7bf3521d3e7162025-01-15T04:11:45ZengElsevierAACE Clinical Case Reports2376-06052025-01-011114548Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-GanglioneuromaMayssam El Najjar, MD0Elie Naous, MD1Caroline Blake2Aysegul Bulut, MD3Alexander Perepletchikov, MD4Ann T. Sweeney, MD5Department of Medicine, St Elizabeth’s Medical Center, Brighton, MassachusettsDepartment of Medicine, St Elizabeth’s Medical Center, Brighton, MassachusettsDepartment of Medicine, St Elizabeth’s Medical Center, Brighton, MassachusettsDepartment of Medicine, Division of Endocrinology, Boston Medical Center, Boston, MassachusettsProfessional Pathology Services, Professional Corporation, Hilton Head Hospital, Hilton Head Island, South CarolinaDepartment of Medicine, Division of Endocrinology, St Elizabeth’s Medical Center, Brighton, Massachusetts; Address correspondence to Dr Ann T. Sweeney, Department of Medicine, Division of Endocrinology, St Elizabeth’s Medical Center, 736 Cambridge Street, Brighton, MA 02135.Background/Objective: In <10% of cases, pheochromocytomas coexist with other tumors, most commonly ganglioneuromas, and are termed composite pheochromocytoma-ganglioneuromas. We present 2 cases of composite pheochromocytoma-ganglioneuromas and review the diagnosis and management of these rare tumors. Case Report: Patient 1 and patient 2 were 35-year-old and 45-year-old woman, respectively. Patient 1 presented with a history of controlled hypertension and symptoms of anxiety along with palpitations, diaphoresis, and flushing. Patient 2 complained of abdominal pain and underwent abdominal computed tomography (CT) imaging. Patient 1 and patient 2 had metanephrine levels of 76 pg/mL and 61 pg/mL (normal <57 pg/mL), respectively, and normetanephrine levels of 161 pg/mL and 116 pg/mL (normal < 148 pg/mL), respectively. CT scans depicted right adrenal masses in both cases: patient 1 had a 2.3 × 2.6 cm mass measuring 36 Hounsfield units on noncontrast CT imaging and patient 2 had a 4.5 × 3.5 cm right adrenal mass measuring 73 Hounsfield units on contrast CT imaging. Both patients underwent laparoscopic robotic adrenalectomies without complications. The pathologic analyses of both cases revealed composite pheochromocytoma-ganglioneuroma tumors. Surveillance at 1 year in both patients demonstrated no evidence of recurrence. Discussion: The clinical and radiological presentation of composite pheochromocytoma-ganglioneuromas mirrors pheochromocytomas. The diagnosis relies on histopathological analysis. Treatment of pheochromocytoma-ganglioneuromas is complete surgical excision in a high-volume center with adrenal expertise and is associated with an overall excellent prognosis. The probability of recurrence is low, and distant metastases have rarely been reported. Conclusion: Pheochromocytoma-ganglioneuromas may present with plasma metanephrine levels in the subclinical range. As with isolated pheochromocytomas, lifetime surveillance is critical for composite pheochromocytoma-ganglioneuromas.http://www.sciencedirect.com/science/article/pii/S2376060524001123composite tumorpheochromocytoma-ganglioneuromasubclinical pheochromocytomadiagnosistreatment
spellingShingle Mayssam El Najjar, MD
Elie Naous, MD
Caroline Blake
Aysegul Bulut, MD
Alexander Perepletchikov, MD
Ann T. Sweeney, MD
Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma
AACE Clinical Case Reports
composite tumor
pheochromocytoma-ganglioneuroma
subclinical pheochromocytoma
diagnosis
treatment
title Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma
title_full Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma
title_fullStr Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma
title_full_unstemmed Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma
title_short Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma
title_sort two cases of composite pheochromocytoma ganglioneuromas with plasma metanephrine levels in the subclinical range pheochromocytoma ganglioneuroma
topic composite tumor
pheochromocytoma-ganglioneuroma
subclinical pheochromocytoma
diagnosis
treatment
url http://www.sciencedirect.com/science/article/pii/S2376060524001123
work_keys_str_mv AT mayssamelnajjarmd twocasesofcompositepheochromocytomaganglioneuromaswithplasmametanephrinelevelsinthesubclinicalrangepheochromocytomaganglioneuroma
AT elienaousmd twocasesofcompositepheochromocytomaganglioneuromaswithplasmametanephrinelevelsinthesubclinicalrangepheochromocytomaganglioneuroma
AT carolineblake twocasesofcompositepheochromocytomaganglioneuromaswithplasmametanephrinelevelsinthesubclinicalrangepheochromocytomaganglioneuroma
AT aysegulbulutmd twocasesofcompositepheochromocytomaganglioneuromaswithplasmametanephrinelevelsinthesubclinicalrangepheochromocytomaganglioneuroma
AT alexanderperepletchikovmd twocasesofcompositepheochromocytomaganglioneuromaswithplasmametanephrinelevelsinthesubclinicalrangepheochromocytomaganglioneuroma
AT anntsweeneymd twocasesofcompositepheochromocytomaganglioneuromaswithplasmametanephrinelevelsinthesubclinicalrangepheochromocytomaganglioneuroma